Business UpdateMay 28, 2026, 01:01 AM
argenx to Host R&D Spotlight Webinar on Autoimmune Myositis
AI Summary
argenx announced it will host a webinar titled "R&D Spotlight: Advancing FcRn Leadership into Autoimmune Myositis" on Tuesday, June 23, 2026, at 2:00pm ET. This webinar is part of a 'mini' series highlighting the company's pipeline and R&D strategy, focusing on myositis, a severe autoimmune rheumatic disease. The event will feature discussions on disease biology, the ALKIVIA clinical program design, and the clinical and commercial potential of efgartigimod.
Key Highlights
- argenx to host an R&D Spotlight webinar on June 23, 2026, at 2:00pm ET.
- Webinar will focus on advancing FcRn leadership into autoimmune myositis.
- Discussion will include emerging insights into myositis disease biology and autoantibodies.
- ALKIVIA clinical program design will be presented.
- Clinical and commercial opportunity for efgartigimod will be discussed.
- Webcast accessible via argenx.com/investors, with replay available for one year.
Price Impact
More from ARGX